Amrutanjan Health Care Limited
2,629words
8turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
9%
19%
14%
10%
8%
16%
21%
17%
4%
22%
12%
Guidance — 14 items
Exceptional items
opening
“The Company has assessed and disclosed for the incremental impact of these changes on the basis of best information available, consistent with the guidance provided by the Institute of Chartered Accountants of India.”
Operating Segments
opening
“Investor Presentation | Quarter and Year Ended 31st March 2026 Financials – Q4 FY26 (Rs.”
Operating Segments
opening
“in Crores) Net Sales 149.77 135.41 Profit before exceptional items 28.62 20.86 Q4 FY26 Q4 FY25 Q4 FY26 Q4 FY25 Growth: 10.60% Profit Before Tax 21.02 20.86 Q4 FY26 Q4 FY25 Growth: 0.77% Investor Presentation | Quarter and Year Ended 31st March 2026 Growth: 37.20% Profit After Tax 16.19 15.18 Q4 FY26 Q4 FY25 Growth: 6.65% Segment results – Q4 FY26 (Rs.”
Operating Segments
opening
“in Crores) Net Sales – OTC Products 132.63 117.24 Q4 FY26 Q4 FY25 Growth: 13.13% Net Sales – Women’s Hygiene & Personal Care 41.84 34.46 Q4 FY26 Q4 FY25 Growth: 21.42% Net Sales – Comfy (Included in above) 40.79 34.46 Investor Presentation | Quarter and Year Ended 31st March 2026 # Comfy growth in gross sales(before IND AS 115 adjustment) is 22% Q4 FY26 Q4 FY25 # Growth: 18.37% Segment results – Q4 FY26 (Rs.”
Operating Segments
opening
“in Crores) Investor Presentation | Quarter and Year Ended 31st March 2026 Net Sales - Beverages 16.42 17.67 Q4 FY26 Q4 FY25 Net Sales – Hydration drinks (Included in above) 15.47 16.21 Q4 FY26 Q4 FY25 Financials – FY26 (Rs.”
Operating Segments
opening
“in Crores) Net Sales 502.55 451.82 FY26 FY25 Growth: 11.23% Profit Before Tax 77.89 69.13 Profit before exceptional items 86.74 69.13 FY26 FY25 Growth: 25.47% Profit After Tax 57.92 50.83 FY26 FY25 FY26 FY25 Investor Presentation | Quarter and Year Ended 31st March 2026 Growth: 12.67% Growth: 13.95% Segment results –FY26 (Rs.”
Operating Segments
opening
“in Crores) Net Sales – OTC Products 468.22 413.99 FY26 FY25 Growth: 13.10% Net Sales – Women’s Hygiene & Personal Care 139.91 123.96 FY26 FY25 Growth: 12.87% Net Sales – Comfy (Included in above) 138.86 123.96 FY26 FY25 Growth: 12.02% #”
Notes
opening
“• Majority of Raw material & Packing material prices are lower than FY25.”
Notes
opening
“Menthol Crystal price is marginally lower than FY25.”
Notes
opening
“• Advertisement spend for FY26 is at Rs.”
Risks & concerns — 2 flagged
The Company has assessed and disclosed for the incremental impact of these changes on the basis of best information available, consistent with the guidance provided by the Institute of Chartered Accountants of India.
— Exceptional items
Considering the materiality and regulatory-driven, non-recurring nature of this impact, the Company has presented such incremental impact as "Impact of new Labour Codes" under "Exceptional items" in the financial results for the year ended 31 March 2026.
— Exceptional items
Speaking time
1
1
1
1
1
1
1
1
Opening remarks
Rehydration
35.6 Crs Investor Presentation | Quarter and Year Ended 31st March 2026 FY 25-26: Pain Management and Women’s Hygiene witnessed double digit growth (Gross Sales Growth) Pain Management Congestion Women’s Hygiene Rehydration Brand Amrutanjan Brand Relief Brand Comfy Growth FY 25-26 Growth FY 25-26 Growth FY 25-26 Brand Electro+ Growth FY 25-26 Relief Range 9% Overall Comfy 19% Electro+ -14% Overall Pain Category Head ache Body ache 10% 8% 16% Investor Presentation | Quarter and Year Ended 31st March 2026 Segment Performance: Pain Management Head ache (Brand Amrutanjan) Body ache (Brand Amrutanjan) Gross Sales Growth Drivers (FY 25-26): All variants (Yellow Balm, White Balm and Head Roll On) contributed to the growth Gross Sales Growth Drivers (FY 25-26): Growth led by Back Pain Roll On (BPRO) and Maha Strong Head Roll On Big SKUs (27.5ml & 50ml) 8ml 21% 17% 4% Head Roll On’s growth was driven by both distribution increase and offtake growth Maha Strong BPRO 22% 12% Investor Presentation
Exceptional items
➢ During the financial year 2005-06, the Government of Tamil Nadu retrospectively revised the lease rent for a leasehold land, effective from November 2001, by determining fair rent under Section 34A of the Tamil Nadu Hindu Religious and Charitable Endowments Act, 1959. Pursuant to this revision, a demand notice was issued to the Company. Accordingly, the Company had filed a Writ Petition before the High Court of Judicature, Madras challenging the fair rent determination, contending that the revision was exorbitant and not legally tenable. On 25 September 2025, the High Court of Judicature, Madras dismissed the petition and upheld the rent fixed by the Fair Rent Committee constituted by the Government of Tamil Nadu. Based on the advice from the external consultant, the Company filed an appeal on 9 December 2025 before the Division Bench of the High Court of Judicature, Madras and the appeal was dismissed on 16 March 2026. Accordingly the Company has created a provision and presented un
Operating Segments
➢ Pursuant to launch of New products Women's Hygiene is renamed as ‘Women's Hygiene & Personal Care’. Investor Presentation | Quarter and Year Ended 31st March 2026 Financials – Q4 FY26 (Rs. in Crores) Net Sales 149.77 135.41 Profit before exceptional items 28.62 20.86 Q4 FY26 Q4 FY25 Q4 FY26 Q4 FY25 Growth: 10.60% Profit Before Tax 21.02 20.86 Q4 FY26 Q4 FY25 Growth: 0.77% Investor Presentation | Quarter and Year Ended 31st March 2026 Growth: 37.20% Profit After Tax 16.19 15.18 Q4 FY26 Q4 FY25 Growth: 6.65% Segment results – Q4 FY26 (Rs. in Crores) Net Sales – OTC Products 132.63 117.24 Q4 FY26 Q4 FY25 Growth: 13.13% Net Sales – Women’s Hygiene & Personal Care 41.84 34.46 Q4 FY26 Q4 FY25 Growth: 21.42% Net Sales – Comfy (Included in above) 40.79 34.46 Investor Presentation | Quarter and Year Ended 31st March 2026 # Comfy growth in gross sales(before IND AS 115 adjustment) is 22% Q4 FY26 Q4 FY25 # Growth: 18.37% Segment results – Q4 FY26 (Rs. in Crores) Investor Presentation | Quarter
Notes
• Majority of Raw material & Packing material prices are lower than FY25. Menthol Crystal price is marginally lower than FY25. • Advertisement spend for FY26 is at Rs. 39 Cr against Rs. 33.92 Cr for FY25. Advertisement spend for Comfy is at Rs. 9.56 Cr for FY26 against Rs. 8.03 Cr for FY25. # Comfy growth in gross sales (before IND AS 115 adjustment) is 19% Investor Presentation | Quarter and Year Ended 31st March 2026 Segment results –FY26 (Rs. in Crores) Net Sales - Beverages 31.56 36.43 FY26 FY25 Net Sales - Electro Plus (Included in above) 29.23 32.47 FY26 FY25 Investor Presentation | Quarter and Year Ended 31st March 2026 • Raw material prices are higher than FY25 and Packing material prices are marginally lower than FY25. • Advertisement spend for FY26 is at Rs. 3.47 Cr against Rs. 5.89 Cr for FY25. Expenses – FY26 (Rs. in Crores) Employee Benefit Expenses 63.76 59.10 FY26 FY25 Increase : 7.88% Advertisement & Selling Expenses 60.04 56.11 Other Expenses 58.71 55.20 FY26 FY25 Incr
Outlook
a) We are confident about the demand environment going into the new year as we have unique value propositions that would continue to drive growth. b) We are planning to relaunch our Congestion brand Relief this year c) We will see COGS inflation this year related to the Middle East wars that are affecting crude prices and supply chains. We are mitigating these by price increases to some extent. d) Our new Sanitary Pad plant is slated to commence production in May and should improve profitability of Comfy brand in the new year. e) 68% of the processes in AHCL are digitized and with the full implementation of DMS(Distributor Management System) and SAP TM( Transport Module)this year, we would have achieved close to 85% ,and a high level of automation and controls of core organizational processes and systems. Investor Presentation | Quarter and Year Ended 31st March 2026 Investor Presentation | Quarter and Year Ended 31st March 2026